{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:20:51Z","timestamp":1790360451399,"version":"4.1.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T00:00:00Z","timestamp":1499212800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9,11]]},"DOI":"10.1093\/imammb\/dqx006","type":"journal-article","created":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T15:08:04Z","timestamp":1496761684000},"page":"347-361","source":"Crossref","is-referenced-by-count":7,"title":["Modelling recurrence and second cancer risks induced by proton therapy"],"prefix":"10.1093","volume":"35","author":[{"given":"V S K","family":"Manem","sequence":"first","affiliation":[{"name":"Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Dhawan","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,7,4]]},"reference":[{"key":"key\n\t\t\t\t20180911023312_B1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/09553008914550101","article-title":"RBE-LET relationship for the survival of V79 cells irradiated with low energy protons.","volume":"55","author":"Belli","year":"1989","journal-title":"Int. J. Radiat. Biol."},{"key":"key\n\t\t\t\t20180911023312_B2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/09553009214551431","article-title":"Direct comparison of biological effectiveness of protons and alpha-particles of the same LET. II. Mutation induction at the HPRT locus in V79 cells.","volume":"61","author":"Belli","year":"1992","journal-title":"Int. J. Radiat. Biol."},{"key":"key\n\t\t\t\t20180911023312_B3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/095530098141375","article-title":"RBE-LET relationships for cell inactivation and mutation induced by low energy protons in V79 cells: further results at the LNL facility.","volume":"74","author":"Belli","year":"1998","journal-title":"Int. J. Radiat. Biol."},{"key":"key\n\t\t\t\t20180911023312_B4","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-81519-5","author":"Chadwick","year":"1981","journal-title":"The Molecular Theory of Radiation Biology"},{"key":"key\n\t\t\t\t20180911023312_B5","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/rpd\/ncr218","article-title":"Empirical model estimation of relative biological effectiveness for proton beam therapy.","volume":"149","author":"Chen","year":"2012","journal-title":"Radiat. Prot. Dosi."},{"key":"key\n\t\t\t\t20180911023312_B6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/annonc\/2.suppl_2.77","article-title":"Long-term toxicity of early stages of Hodgkin\u2019s disease therapy: the EORTC experience.","volume":"2","author":"Cosset","year":"1991","journal-title":"Ann. Oncol."},{"key":"key\n\t\t\t\t20180911023312_B7","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.1999.17.3.776","article-title":"Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin\u2019s disease and lymphocyte-rich classical Hodgkin\u2019s disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin\u2019s Disease.","volume":"17","author":"Diehl","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"key\n\t\t\t\t20180911023312_B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/707542","article-title":"Outcome of very late relapse in patients with hodgkin\u2019s lymphomas.","volume":"2011","author":"Gaudio","year":"2011","journal-title":"Adv. Hematol."},{"key":"key\n\t\t\t\t20180911023312_B9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1667\/0033-7587(2003)159[0161:LCATFH]2.0.CO;2","article-title":"Lung cancer after treatment for Hodgkin\u2019s disease: focus on radiation effects.","volume":"159","author":"Gilbert","year":"2003","journal-title":"Radiat. Res."},{"key":"key\n\t\t\t\t20180911023312_B10","first-page":"758","article-title":"Survival outcome after Hodgkin\u2019s disease: a report from the international data base on Hodgkin\u2019s disease.","volume":"17","author":"Henry-Amar","year":"1990","journal-title":"Semin. Oncol."},{"key":"key\n\t\t\t\t20180911023312_B11","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1002\/cncr.23081","article-title":"Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma.","volume":"110","author":"Hodgson","year":"2007","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20180911023312_B12","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1200\/JCO.2006.09.0936","article-title":"Long-term solid cancer risk among 5-year survivors of Hodgkin\u2019s Lymphoma.","volume":"25","author":"Hodgson","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"key\n\t\t\t\t20180911023312_B13","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3109\/10428194.2011.608455","article-title":"The unique entity of nodular lymphocyte-predominant Hodgkin lymphoma: current approaches to diagnosis and management.","volume":"53","author":"Hawkes","year":"2012","journal-title":"Leuk. Lymphoma"},{"key":"key\n\t\t\t\t20180911023312_B14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0360-3016(00)00647-7","article-title":"The need for long-term surveillance for patients treated with curative radiotherapy for Hodgkin\u2019s disease: University of Minnesota experience.","volume":"48","author":"Lee","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"key\n\t\t\t\t20180911023312_B15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1259\/bjr.74.882.740529","article-title":"Radiation carcinogenesis modelling for risk of treatment-related second tumours following radiotherapy.","volume":"74","author":"Lindsay","year":"2001","journal-title":"Br. J. Radiol."},{"key":"key\n\t\t\t\t20180911023312_B16","article-title":"Mathematical modeling of secondary malignancies and associated treatment strategies.","volume-title":"Ph. D. Thesis","author":"Manem","year":"2014"},{"key":"key\n\t\t\t\t20180911023312_B17","doi-asserted-by":"crossref","first-page":"20140377","DOI":"10.1259\/bjr.20140377","article-title":"Efficacy of dose escalation on TCP, recurrence and second cancer risks: a mathematical study.","volume":"87","author":"Manem","year":"2014","journal-title":"Br. J. Radiol."},{"key":"key\n\t\t\t\t20180911023312_B18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/09553002.2014.980466","article-title":"The effect of radiation quality on the risks of second malignancies. Int.","volume":"91","author":"Manem","year":"2015","journal-title":"J. Radiat. Biol."},{"key":"key\n\t\t\t\t20180911023312_B19","first-page":"33","article-title":"Long-term survival in Hodgkin\u2019s disease relative impact of mortality, second tumors, infection, and cardiovascular disease.","volume":"1","author":"Mauch","year":"1995","journal-title":"Cancer J. Sci. Am."},{"key":"key\n\t\t\t\t20180911023312_B20","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00285-008-0222-y","article-title":"Linear quadratic and tumour control probability modelling in external beam radiotherapy.","volume":"58","author":"O\u2019Rourke","year":"2009","journal-title":"J. Math. Biol."},{"key":"key\n\t\t\t\t20180911023312_B21","doi-asserted-by":"crossref","first-page":"R419","DOI":"10.1088\/0031-9155\/59\/22\/R419","article-title":"Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer.","volume":"59","author":"Paganetti","year":"2014","journal-title":"Phys. Med. Biol."},{"key":"key\n\t\t\t\t20180911023312_B22","doi-asserted-by":"crossref","first-page":"13040","DOI":"10.1073\/pnas.0506648102","article-title":"Solid tumor risks after high doses of ionizing radiation.","volume":"102","author":"Sachs","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"key\n\t\t\t\t20180911023312_B23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-4682-7-4","article-title":"Hypofractionated radiotherapy has the potential for second cancer reduction.","volume":"7","author":"Schneider","year":"2010","journal-title":"Theoret. Biol. Med. Model."},{"key":"key\n\t\t\t\t20180911023312_B24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jama.290.4.465","article-title":"Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.","volume":"290","author":"Travis","year":"2003","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180911023312_B25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/02841868909111193","article-title":"Tumor cell proliferation kinetics and tumor growth rate.","volume":"28","author":"Tubiana","year":"1989","journal-title":"Acta Oncol."},{"key":"key\n\t\t\t\t20180911023312_B26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1158\/1055-9965.EPI-11-0576","article-title":"Chemotherapy and thyroid cancer risk: a report from the Childhood Cancer Survivor Study.","volume":"21","author":"Veiga","year":"2012","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"key\n\t\t\t\t20180911023312_B27","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1120\/jacmp.v11i1.3042","article-title":"Helical tomotherapy in the radiotherapy treatment of Hodgkin\u2019s disease\u2014a feasibility study.","volume":"11","author":"Vlachaki","year":"2010","journal-title":"J. Appl. Clin. Med. Phys."},{"key":"key\n\t\t\t\t20180911023312_B28","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1088\/0031-9155\/49\/13\/004","article-title":"A phenomenological model for the relative biological effectiveness in therapeutic proton beams.","volume":"49","author":"Wilkens","year":"2004","journal-title":"Phys. Med. Biol."},{"key":"key\n\t\t\t\t20180911023312_B29","doi-asserted-by":"crossref","first-page":"R193","DOI":"10.1088\/0031-9155\/53\/13\/R01","article-title":"A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction.","volume":"53","author":"Xu","year":"2008","journal-title":"Phys. Med. Biol."}],"container-title":["Mathematical Medicine and Biology: A Journal of the IMA"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/imammb\/article-pdf\/35\/3\/347\/25692964\/dqx006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T13:38:55Z","timestamp":1569418735000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/imammb\/article\/35\/3\/347\/3925038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,4]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,7,4]]},"published-print":{"date-parts":[[2018,9,11]]}},"URL":"https:\/\/doi.org\/10.1093\/imammb\/dqx006","relation":{},"ISSN":["1477-8599","1477-8602"],"issn-type":[{"value":"1477-8599","type":"print"},{"value":"1477-8602","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,9]]},"published":{"date-parts":[[2017,7,4]]}}}